Management of Acute Intermediate-risk Pulmonary Embolism: Where Do we Stand in the Era of Upcoming Randomized Controlled Trials?

Abstract

The role of catheter-directed therapy, in the form of pharmacologic, mechanical, or combination therapy, remains unclear in the treatment of acute pulmonary embolism. Multiple prospective randomized controlled clinical trials are ongoing in an attempt to answer this critical clinical question. This brief manuscript describes the current randomized controlled trials for this disease process.

Keywords

interventional radiology - pulmonary embolism - catheter-directed therapy - thrombectomy - thrombolysis

Publikationsverlauf

Artikel online veröffentlicht:
28. Oktober 2025

• References

• 1 Machanahalli Balakrishna A, Reddi V, Belford PM. et al. Intermediate-risk pulmonary embolism: a review of contemporary diagnosis, risk stratification and management. Medicina (Kaunas) 2022; 58 (09) 1186
• 2 Zuin M, Bikdeli B, Ballard-Hernandez J. et al. International clinical practice guideline recommendations for acute pulmonary embolism: harmony, dissonance, and silence. J Am Coll Cardiol 2024; 84 (16) 1561-1577
• 3 Sista AK, Troxel AB, Tarpey T. et al. Rationale and design of the PE-TRACT trial: a multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism. Am Heart J 2025; 281: 112-122
• 4 Klok FA, Piazza G, Sharp ASP. et al. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study. Am Heart J 2022; 251: 43-53
• 5 Giri J, Mahfoud F, Gebauer B. et al. PEERLESS II: a randomized controlled trial of large-bore thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism. J Soc Cardiovasc Angiogr Interv 2024; 3 (06) 101982
• 6 Penumbra Inc. Comparison of Two Pulmonary Embolism Treatments. Clinicaltrials.gov. February 6, 2025. Accessed April 16, 2025 at: https://clinicaltrials.gov/study/NCT05684796#contacts-and-locations
• 7 STORM-PE TRIAL | Penumbra Inc. Penumbra, Inc. Published August 31, 2023. Accessed April 16, 2025 at: https://www.penumbrainc.com/storm-pe-trial/
• 8 Sanchez O, Charles-Nelson A, Ageno W. et al; PEITHO-3 Investigators. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost 2022; 122 (05) 857-866